ClearStream/Cordis PTA (percutaneous transluminal angioplasty) balloon catheter deal expands:
This article was originally published in Clinica
Executive Summary
Johnson & Johnson-subsidiary Cordis is to offer a broader range of percutaneous transluminal angioplasty (PTA) balloon catheters in its Sleek and Savvy Long lines, following the expansion of an existing agreement with the devices' manufacturer ClearStream Technologies. Cordis' endovascular division has been marketing Sleek and Savvy Long balloons of up to 200mm in length outside the US since May 2007. It expects the new catheters - which include lengths of up to 220mm - to be available in non-US market from October 2007, and in the US in the first quarter of 2008.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.